ACE and liver dysplastic nodule: ACE inhibitors [12] and ARBs [13, 14] have demonstrated the ability to protect renal function of DN but are not enough to retard the progression, and they are not recommended for the primary prevention of DN in patients who have normal blood pressure and normal UACR.